Vitamin B12 injections versus oral supplements: How much money could be saved by switching from injections to pills?

Canadian Family Physician

Volumn 47, Issue JAN., 2001, Pages 79-86

  Van Walraven, Carl ^b   Austin, Peter ^b   Naylor, C David ^b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; INTRINSIC FACTOR; METHYLMALONIC ACID;

AGED; ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; PERNICIOUS ANEMIA; STATISTICAL MODEL; VITAMIN SUPPLEMENTATION; ECONOMICS; ELDERLY CARE; FACTUAL DATABASE; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; COST SAVINGS; DATABASES, FACTUAL; DRUG COSTS; FEMALE; HEALTH SERVICES FOR THE AGED; HUMANS; INJECTIONS, INTRAMUSCULAR; INSURANCE, HEALTH; MALE; VITAMIN B 12;

EID: 0034745950     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lederle FA. Oral cobalamin for pernicious anemia. Medicine's best kept secret. JAMA 1991;265:94-5.
2. 12 without intrinsic factor. Acta Med Scand 1968;184:247-58.
3. 12 without intrinsic factor in the treatment of pernicious anemia. Ann Intern Med 1963;58:810-7.
4. 12 body stores during oral and parenteral treatment of pernicious anaemia. Acta Med Scand 1978;204:81-4.
5. Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92:1191-8.
6. Lederle FA. Cyanocobalamin - a case for withdrawal. J R Soc Med 1993;86:308-9.
7. Stabler SP, Lindenbaum J, Allen RH. Vitamin B-12 deficiency in the elderly: current dilemmas. Am J Clin Nutrition 1997;66:741-9.
8. Pruthi RK, Tefferi A. Pernicious anemia revisited. Mayo Clin Proc 1994;69:144-50.
9. 12 replacement therapy: how much is enough? Wisc Med J 1994;93:203-5.
10. Markle HV. Cobalamin. Crit Rev Clin Lab Sci 1996;33:247-356.
11. 12? Can Fam Physician 1997;43:917-22.
12. 12 deficiency. Lancet 1998;352:1721-2.
13. 12 serum levels in older people by oral treatment. J Am Geriatr Soc 1997;45:124-5.
14. 12 malabsorption. J Pediatr Hematol Oncol 1997;19:245-6.
15. Lederle FA. Oral cobalamin for pernicious anemia: back from the verge of extinction. J Am Geriatr Soc 1998;46:1125-7.
16. 12 injections. Br Med J Clin Res Ed 1985;291:56.
17. 12 injections: considerable source of work for the district nurse. Br Med J Clin Res Ed 1985;290:1254-5.
18. Hathcock JN, Troendle GJ. Oral cobalamin for treatment of pernicious anemia? JAMA 1991;265:96-7.
19. Sonnenberg FA, Roberts MS, Tsevat J, Wong JB, Barry M, Kent DL. Toward a peer review process for medical decision analysis models. Med Care 1994;32(Suppl 7):JS52-JS64.
20. Cameron AC, Trivedi PK. Regression analysis of count data. Cambridge, Engl: Cambridge University Press; 1998.
21. Naglie G, Tansey C, Krahn MD, O'Rourke K, Detsky AS, Bolley H. Direct costs of coronary artery bypass grafting in patients aged 65 years or more and those under age 65. Can Med Assoc J 1999;160:805-11.
22. Borsellino M. Overwork, stress rural doctors' companion. Med Post 1997;32(33):2.
23. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992;146:473-81.
24. Savage D, Lindenbaum J. Relapses after interruption of cyanocobalamin therapy in patients with pernicious anemia. Am J Med 1983;74:765-72.